Shandong Kexing Bioproducts Co,.Ltd (688136.SS)
CNY 20.64
(5.84%)
CNY 20.64
(5.84%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.25 Billion | 1.31 Billion | 1.28 Billion | 1.22 Billion | 1.19 Billion | 890.61 Million |
| Cost of Revenue | 370.31 Million | 324.16 Million | 264.62 Million | 244.26 Million | 219.95 Million | 168.24 Million |
| Gross Profit | 888.72 Million | 991.71 Million | 1.02 Billion | 976.02 Million | 970.81 Million | 722.37 Million |
| Operating Expenses | 1.12 Billion | 1.11 Billion | 974.79 Million | 792.23 Million | 760.91 Million | 580.34 Million |
| Selling, General and Administrative Expenses | 713.31 Million | 856.17 Million | 785.49 Million | 675.59 Million | 669.94 Million | 522.15 Million |
| Research and Development Expenses | 344.79 Million | 193.29 Million | 122.95 Million | 60.11 Million | 46.16 Million | 42.67 Million |
| Other Expenses | - | 62.04 Million | 66.34 Million | 56.53 Million | 44.8 Million | -1687.61 |
| Cost and Expenses | 1.51 Billion | 1.43 Billion | 1.23 Billion | 1.03 Billion | 980.86 Million | 748.58 Million |
| Operating Income | -254.2 Million | -119.8 Million | 55.56 Million | 159.84 Million | 188.98 Million | 121.27 Million |
| Interest Expense | 39.13 Million | 26.3 Million | 8.02 Million | 10.32 Million | 6.66 Million | 11.15 Million |
| Income Tax Expense | -64.58 Million | -46.24 Million | -836.84 Thousand | 20.01 Million | 27.97 Million | 27.1 Million |
| Earnings before Tax | -260.06 Million | -139.06 Million | 95.62 Million | 159.15 Million | 187.78 Million | 121.26 Million |
| Net Income | -190.29 Million | -92.82 Million | 96.46 Million | 139.13 Million | 159.81 Million | 94.16 Million |
| Earnings Per Share Basic | -0.96 | -0.47 | 0.49 | 0.70 | 0.80 | 1.54 |
| Earnings Per Share Diluted | -0.96 | -0.47 | 0.49 | 0.70 | 0.80 | 1.54 |
| Weighted Average Shares Outstanding | 198.21 Million | 198.7 Million | 198.7 Million | 198.7 Million | 198.7 Million | 61.14 Million |
| Weighted Average Shares Outstanding (Diluted) | 198.21 Million | 198.7 Million | 198.7 Million | 198.7 Million | 198.7 Million | 61.14 Million |
| Gross Margin | 0.71 | 0.75 | 0.79 | 0.80 | 0.82 | 0.81 |
| EBIT Margin | -0.10 | -0.03 | 0.08 | 0.17 | 0.19 | 0.18 |
| Profit Margin | -0.15 | -0.07 | 0.08 | 0.11 | 0.13 | 0.11 |
| EBITDA | -119.68 Million | -28.86 Million | 164.81 Million | 209.74 Million | 213.89 Million | 143.81 Million |
| Earnings Before Tax Margin | -0.20 | -0.09 | 0.04 | 0.13 | 0.16 | 0.14 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 278.36 Million | 396.07 Million | 360.66 Million | 1.25 Billion | 290.03 Million | 320.03 Million |
| Cost of Revenue | 95.48 Million | 133.84 Million | 98.68 Million | 367.75 Million | 91.7 Million | 93.53 Million |
| Gross Profit | 182.88 Million | 262.22 Million | 261.98 Million | 891.28 Million | 198.33 Million | 226.49 Million |
| Operating Expenses | 164 Million | 211.92 Million | 234.81 Million | 1.51 Billion | 471.72 Million | 217.57 Million |
| Selling, General and Administrative Expenses | 202.83 Million | 173.16 Million | 197.17 Million | - | 116.84 Million | 201.9 Million |
| Research and Development Expenses | 33.12 Million | 37.67 Million | 35.2 Million | - | 176.43 Million | 44.05 Million |
| Other Expenses | -71.95 Million | -1.08 Million | 93.15 Thousand | -1.51 Billion | -471.72 Million | -2 Million |
| Cost and Expenses | 259.48 Million | 345.76 Million | 333.49 Million | 1.51 Billion | 471.72 Million | 311.11 Million |
| Operating Income | 7.96 Million | 50.3 Million | 15.84 Million | -254.2 Million | -181.68 Million | 495 Thousand |
| Interest Expense | 11.3 Million | 11.2 Million | 10.03 Million | 39.13 Million | 9.21 Million | 10.34 Million |
| Income Tax Expense | 3.62 Million | 28.07 Million | 4.44 Million | -64.58 Million | -47.84 Million | 6.69 Million |
| Earnings before Tax | 7.91 Million | 26.04 Million | 15.93 Million | -258.04 Million | -183.17 Million | -1.5 Million |
| Net Income | 5.3 Million | -526.11 Thousand | 12.4 Million | -189.57 Million | -131.44 Million | -6.75 Million |
| Earnings Per Share Basic | 0.03 | -0.00 | 0.06 | - | -0.86 | -0.03 |
| Earnings Per Share Diluted | 0.03 | -0.00 | 0.06 | - | -0.86 | -0.03 |
| Weighted Average Shares Outstanding | 197.31 Million | 197.31 Million | 206.72 Million | 198.21 Million | 152.33 Million | 199.19 Million |
| Weighted Average Shares Outstanding (Diluted) | 197.31 Million | 197.31 Million | 206.72 Million | 198.21 Million | 152.33 Million | 199.19 Million |
| Gross Margin | 0.66 | 0.66 | 0.73 | 0.71 | 0.68 | 0.71 |
| EBIT Margin | 0.07 | 0.19 | 0.08 | - | -0.54 | 0.03 |
| Profit Margin | 0.02 | -0.00 | 0.03 | -0.15 | -0.45 | -0.02 |
| EBITDA | 19.22 Million | 75.93 Million | 30.14 Million | - | -157 Million | 9.88 Million |
| Earnings Before Tax Margin | 0.03 | 0.13 | 0.04 | -0.20 | -0.63 | 0.00 |
092040
CMXHF
EESE
1618
SHBAJRG
300801